Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis

Keyphrases

• Nanoparticles 100%
• MicroRNA 100%
• Restenosis 100%
• Cell-selective 40%
• Wire Injury 40%
• Lung 20%
• Mouse Model 20%
• Endothelial Cells 20%
• Cardiovascular Disease 20%
• Endothelium 20%
• Femoral Artery 20%
• Nuclease 20%
• Cell-penetrating Peptide 20%
• Spleen 20%
• Cause of Death 20%
• Targeted Sequencing 20%
• Intimal Hyperplasia 20%
• 5′-untranslated Region (5′-UTR) 20%
• Repeated Administration 20%
• Neointima Formation 20%
• Percutaneous Intervention 20%
• Atherosclerotic Plaque Rupture 20%
• Re-epithelialization 20%
• P27Kip1 20%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 20%
• Achilles Heel 20%
• Switch Therapy 20%
• MiR-126 20%
• Modified mRNA 20%
• Neointimal Growth 20%
• Endothelial Denudation 20%
• Selective Treatment 20%
• Causes of Disability 20%
• Effective Delivery 20%
• Nanotherapy 20%
• Lysosomal Acidification 20%
• Liver-kidney 20%

Medicine and Dentistry

• microRNA 100%
• Restenosis 100%
• Nanoparticle 100%
• Messenger RNA 40%
• Endothelial Cell 20%
• Atherosclerosis 20%
• Cardiovascular Disease 20%
• Femoral Artery 20%
• Cell Penetrating Peptide 20%
• Repeated Drug Dose 20%
• Neointima 20%
• Percutaneous Intervention 20%
• Neointimal Hyperplasia 20%
• Nuclease 20%
• Cyclin Dependent Kinase Inhibitor 20%
• microRNA 126 20%
• Lung 20%
• Atherosclerotic Plaque 20%
• Endothelium 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• microRNA 100%
• Restenosis 100%
• Messenger RNA 40%
• Cyclin Dependent Kinase Inhibitor 20%
• Mouse Model 20%
• Atherosclerosis 20%
• Cell Penetrating Peptide 20%
• Hyperplasia 20%
• Nuclease 20%
• Neointima 20%
• microRNA 126 20%
• Cardiovascular Disease 20%
• Atherosclerotic Plaque 20%